The MSI-2 mRNA expression was highly overexpressed in a variety of cancer types, including cervical, breast, head and neck, kidney papillary, lung, sarcoma, skin melanoma, and thyroid cancer as compared to the corresponding normal tissues (Fig. 1d). This evidence concerns the gene MSI2 and cutaneous melanoma.